Merck to donate 3 million doses of Gardasil to poor countries
Merck to donate 3 million doses of Gardasil to poor countries
NEW YORKMerck & Co. has committed to donate at least 3 million doses of it human papillomavirus vaccine Gardasil over the next 5 years for use in demonstration projects in lowest income nations throughout the world. The company made the announcement at the Clinton Global Initiative 2007 meeting. "We are committing to the vaccination of 1 million females against cervical cancer," said Merck's Margaret McGlynn.
Articles in this issue
BRCA1 overexpression is strongly linked to poor outcome in NSCLC patients treated with cisplatin
Bill aims to 'revitalize' FDA by adding powers and databases
New myeloma trial results; two new studies initiated
Neoadjuvant trastuzumab increases pCR rates
Court rejects right of terminally ill to unproven drugs
Sorafenib improves overall survival in Asian HCC pts
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recent Videos
Related Content
!["[The Teal Wand] offers an evidence-based way to expand access [to screening] without compromising accuracy,” according to Christine Conageski, MD, MSc, from the University of Colorado Anschutz Medical Campus.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2Fc41c601528cfbdb8b14b609e326649f33f596c38-1200x675.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "\"[The Teal Wand] offers an evidence-based way to expand access [to screening] without compromising accuracy,” according to Christine Conageski, MD, MSc, from the University of Colorado Anschutz Medical Campus.")
